Procter & Gamble (PG) shares will be underpinned by the steady fiscal year outlook after "better-than-feared" Q2 results proved to be "good enough," UBS Securities said Wednesday in a report.
"We expect the feasibility of the H2 ramp will continue to be debated to a degree, but in an environment where top and bottom-line momentum for many staples companies is not trending in the right direction, we think the sequential improvement narrative will continue to drive shares higher in the coming months," UBS said.
The UBS earnings estimate for the fiscal year remained at $6.91 a share. Procter & Gamble on Wednesday maintained its fiscal 2025 core EPS guidance of $6.91 to $7.05.
Fiscal Q2 results rose more than expected by analysts, buoyed by revenue gains across the majority of business segments.
UBS maintained its buy rating on Procter & Gamble with a $189 price target.
Price: 165.50, Change: +0.76, Percent Change: +0.46
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。